Found 0 matching trials
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease PHASE2 The purpose of the study is to determine the appropriate dose of fluticason...
Show More Learn More & Join Trial
Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) PHASE2 The goal of the study is to evaluate the safety and tolerability of P-1037 ...
Show More Location
Children's Hospital of Los Angeles
Learn More & Join Trial
A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 A dose ranging study to evaluate the safety, tolerability and efficacy of a...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg PHASE2 This is a 16 week multicentre, multinational, randomised, double-blind, dou...
Show More Location
205.342.43002 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery PHASE2 Lung injury in patients undergoing oesophagectomy may occur during surgery ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation PHASE2 The purpose of this study is to investigate whether inhaled epoprostenol gi...
Show More Location
Ohio State University
Learn More & Join Trial
Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD) PHASE3 This study is a phase III clinical study to assess the efficacy and safety ...
Show More Location
Anhui Medical University - Hefei First People's Hospital
Learn More & Join Trial
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) PHASE2 To evaluate the dose-response of different doses of CHF 1531 pressurized me...
Show More Location
Chiesi Investigational Site
Learn More & Join Trial
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 PHASE2 Subjects who have documented exposure to SARS-CoV-2 (COVID-19) will receive...
Show More Location
University of California Irvine
Learn More & Join Trial
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis NA Previous work demonstrated that inhaled hypertonic saline (HS) reduces exac...
Show More Location
University of North Carolina
Learn More & Join Trial